MEDISAFE 1 TECHNOLOGIES CORP: 10-Q filed 2013-07-12

Name: MEDISAFE 1 TECHNOLOGIES CORP: 10-Q filed 2013-07-12
Creator: MEDISAFE 1 TECHNOLOGIES CORP
License: https://creativecommons.org/licenses/by/4.0/

What MEDISAFE 1 TECHNOLOGIES CORP reported in its quarterly report filed 2013-07-12 (fiscal Q2 2013): 21 published measures, 77 facts as tagged in accession 0001144204-13-039209.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-07-12
Fiscal period: fiscal Q2 2013
Accession: 0001144204-13-039209 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All MEDISAFE 1 TECHNOLOGIES CORP filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-06-30	33,681	USD
At 2012-12-31	400,211	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2013-06-30	75,084	USD
At 2012-12-31	63,807	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2013-06-30	-41,403	USD
At 2012-12-31	336,404	USD
At 2011-12-31	-123,070	USD
At 2010-12-31	653	USD
At 2009-12-31	-121,514	USD
At 2009-07-06	0	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2013-06-30	681	USD
At 2012-12-31	211	USD
At 2012-06-30	24	USD
At 2011-12-31	528	USD
At 2009-07-06	0	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	-49,192	USD	91
2013-01-01 to 2013-06-30	-333,331	USD	181
2009-07-07 to 2013-06-30	-1,252,157	USD	1455
2012-01-01 to 2012-12-31	811,809	USD	366
2012-04-01 to 2012-06-30	-151,540	USD	91
2012-01-01 to 2012-06-30	-299,868	USD	182
2011-01-01 to 2011-12-31	-1,343,786	USD	365
2010-01-01 to 2010-12-31	-264,735	USD	365
2009-07-07 to 2009-12-31	-122,114	USD	178

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	-58,303	USD	181
2009-07-07 to 2013-06-30	-457,555	USD	1455
2012-01-01 to 2012-06-30	-27,693	USD	182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	0	USD	91
2013-01-01 to 2013-06-30	0	USD	181
2009-07-07 to 2013-06-30	1,800,000	USD	1455
2012-04-01 to 2012-06-30	0	USD	91
2012-01-01 to 2012-06-30	0	USD	182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	58,773	USD	181
2009-07-07 to 2013-06-30	458,236	USD	1455
2012-01-01 to 2012-06-30	46,254	USD	182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	0	USD	181
2009-07-07 to 2013-06-30	0	USD	1455
2012-01-01 to 2012-06-30	-19,065	USD	182

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2013-04-01 to 2013-06-30	USD	91
2013-01-01 to 2013-06-30	USD	181
2009-07-07 to 2013-06-30	USD	1455
2012-04-01 to 2012-06-30	USD	91
2012-01-01 to 2012-06-30	USD	182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	-27,661	USD	91
2013-01-01 to 2013-06-30	-278,190	USD	181
2009-07-07 to 2013-06-30	-839,154	USD	1455
2012-04-01 to 2012-06-30	-104,869	USD	91
2012-01-01 to 2012-06-30	-208,943	USD	182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2013-06-30	681	USD
At 2012-12-31	211	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2013-06-30	75,084	USD
At 2012-12-31	63,807	USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	0	USD	181
2009-07-07 to 2013-06-30	28,653	USD	1455
2012-01-01 to 2012-06-30	28,653	USD	182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	0	USD	91
2013-01-01 to 2013-06-30	0	USD	181
2009-07-07 to 2013-06-30	123,133	USD	1455
2012-04-01 to 2012-06-30	0	USD	91
2012-01-01 to 2012-06-30	0	USD	182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2013-06-30	867,286,852	shares
At 2012-12-31	649,816,679	shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2013-06-30	-1,767,000	USD
At 2012-12-31	-1,400,000	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2013-06-30	0	USD
At 2012-12-31	0	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	-176,192	USD	91
2013-01-01 to 2013-06-30	-700,331	USD	181
2009-07-07 to 2013-06-30	-3,019,157	USD	1455
2012-04-01 to 2012-06-30	-151,540	USD	91
2012-01-01 to 2012-06-30	-299,868	USD	182

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	0	USD	181
2012-01-01 to 2012-06-30	0	USD	182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	0	USD	181
2009-07-07 to 2013-06-30	165,116	USD	1455
2012-01-01 to 2012-06-30	40,000	USD	182
2009-07-07 to 2009-12-31	600	USD	178

Inspect the source

Entity: MEDISAFE 1 TECHNOLOGIES CORP / CIK 0001471487
Captured: 2026-09-23 02:51 UTC
SEC response SHA-256: c04afc22958039996c393cd09c77eafb0e8e55dea80d114ec407f98c324d6141

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001471487.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))